Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Rohto-Mentholatum (Vietnam) Co., Ltd.

US Class II Ongoing · initiated 2026-07-14

Lack of Assurance of Sterility

Rohto-Mentholatum (Vietnam) Co., Ltd.

US Class II Ongoing · initiated 2026-07-14

Lack of Assurance of Sterility

Apo-Tiotropium 18 mcg Capsules

Canada Type II Ongoing · initiated 2026-07-13

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Oribe Serene Scalp Densifying Shampoo

Canada Type II Ongoing · initiated 2026-07-13

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

BD ChloraPrep™ Clear - 1mL Applicator

Canada Type II Ongoing · initiated 2026-07-13

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

Rising Pharma Holding, Inc.

US Class II Ongoing · initiated 2026-07-13

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

Major Pharmaceuticals

US Class II Ongoing · initiated 2026-07-13

Subpotent Drug

CareFusion 213, LLC

US Class II Ongoing · initiated 2026-07-09

Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2026-07-08

Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

JAMP Chlorthalidone 12.5 mg Tablets

Canada Type III Ongoing · initiated 2026-07-06

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Chiesi USA, Inc.

US Class II Ongoing · initiated 2026-07-06

Lack of Assurance of Sterility

Fludeoxyglucose (18F) Injection

Canada Type III Ongoing · initiated 2026-07-02

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

MYLAN PHARMACEUTICALS INC

US Class II Ongoing · initiated 2026-07-02

Presence of precipitate

Victory Medical Center Pharmacy

US Class I Ongoing · initiated 2026-07-01

Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.